Time-restricted feeding and risk of metabolic disease: A review of human and animal studies

Nutrition Reviews

Volumn 72, Issue 5, 2014, Pages 308-318

  Rothschild, Jeff ^a   Hoddy, Kristin K ^b   Jambazian, Pera ^a   Varady, Krista A ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Coronary heart disease; Intermittent fasting; Metabolic syndrome; Time restricted feeding; Weight loss

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ARTICLE; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; HEALTH STATUS INDICATOR; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; METABOLIC DISORDER; NONHUMAN; RISK ASSESSMENT; TIME RESTRICTED FEEDING; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; EATING; METABOLIC DISEASES; METABOLISM; PHYSIOLOGY; RISK FACTOR;

ANIMALIA;

ANIMALS; BIOLOGICAL MARKERS; EATING; FASTING; HUMANS; METABOLIC DISEASES; RISK FACTORS;

EID: 84899635367     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12104     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention. Prevalence of overweight and obesity in the United States. Available at: http://www.cdc.gov/nchs/fastats/overwt.htm. Updated November 21, 2013. Accessed March 17, 2014.
2. Dulloo AG, Montani JP. Body composition, inflammation and thermogenesis in pathways to obesity and the metabolic syndrome: an overview. Obes Rev. 2012;13(Suppl 2):1-5.
3. Ervin R. Prevalence of Metabolic Syndrome Among Adults 20 Years of Age and Over, by Sex, Age, Race and Ethnicity, and Body Mass Index: United States, 2003-2006. National Health Statistics Reports, no. 13. Hyattsville, MD: National Center for Health Statistics; 2009.
4. Prasad H, Ryan DA, Celzo MF, etal. Metabolic syndrome: definition and therapeutic implications. Postgrad Med. 2012;124:21-30.
5. Varady KA. Intermittent versus daily calorie restriction: which diet regimen is more effective for weight loss? Obes Rev. 2011;12:e593-e601.
6. Varady KA, Bhutani S, Church EC, etal. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009;90:1138-1143.
7. Varady KA, Hellerstein MK. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr. 2007;86:7-13.
8. Mattson MP, Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem. 2005;16:129-137.
9. Trepanowski JF, Canale RE, Marshall KE, etal. Impact of caloric and dietary restriction regimens on markers of health and longevity in humans and animals: a summary of available findings. Nutr J. 2011;10:107. doi:10.1186/1475-2891-10-107.
10. Sherman H, Frumin I, Gutman R, etal. Long-term restricted feeding alters circadian expression and reduces the level of inflammatory and disease markers. J Cell Mol Med. 2011;15:2745-2759.
11. Sherman H, Genzer Y, Cohen R, etal. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. 2012;26:3493-3502.
12. Fonken LK, Workman JL, Walton JC, etal. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci U S A. 2010;107:18664-18669.
13. Hatori M, Vollmers C, Zarrinpar A, etal. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 2012;15:848-860.
14. Belkacemi L, Selselet-Attou G, Louchami K, etal. Intermittent fasting modulation of the diabetic syndrome in sand rats. II. In vivo investigations. Int J Mol Med. 2010;26:759-765.
15. Belkacemi L, Selselet-Attou G, Hupkens E, etal. Intermittent fasting modulation of the diabetic syndrome in streptozotocin-injected rats. Int J Endocrinol. 2012;2012:962012.doi: 10.1155/2012/962012.
16. Farooq N, Priyamvada S, Arivarasu NA, etal. Influence of Ramadan-type fasting on enzymes of carbohydrate metabolism and brush border membrane in small intestine and liver of rat used as a model. Br J Nutr. 2006;96:1087-1094.
17. Salim S, Farooq N, Priyamvada S, etal. Influence of Ramadan-type fasting on carbohydrate metabolism, brush border membrane enzymes and phosphate transport in rat kidney used as a model. Br J Nutr. 2007;98:984-990.
18. Salgado-Delgado R, Angeles-Castellanos M, Saderi N, etal. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinology. 2010;151:1019-1029.
19. Arble DM, Bass J, Laposky AD, etal. Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring). 2009;17:2100-2102.
20. Bray MS, Tsai JY, Villegas-Montoya C, etal. Time-of-day-dependent dietary fat consumption influences multiple cardiometabolic syndrome parameters in mice. Int J Obes (Lond). 2010;34:1589-1598.
21. Tsai JY, Villegas-Montoya C, Boland BB, etal. Influence of dark phase restricted high fat feeding on myocardial adaptation in mice. J Mol Cell Cardiol. 2013;55:147-155.
22. Halberg N, Henriksen M, Soderhamn N, etal. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol (1985). 2005;99:2128-2136.
23. Soeters MR, Lammers NM, Dubbelhuis PF, etal. Intermittent fasting does not affect whole-body glucose, lipid, or protein metabolism. Am J Clin Nutr. 2009;90:1244-1251.
24. Ravanshad S, Setoudehmaram D, Setoudeh ME, etal. Effect of fasting on serum glucose, lipids and keton bodies concentration during Ramadan in Arsenjan-Iran. Iran Red Crescent Med J. 1999;2:23-26. Available at: http://www.medlib.ir/en-us/article/28574774/effect-of-fasting-on-serum-glucose-lipids-and-keton-bodies-concentration-during-ramadan-in-arsenjan-iran. Accessed March 17, 2014.
25. Aksungar FB, Topkaya AE, Akyildiz M. Interleukin-6, C-reactive protein and biochemical parameters during prolonged intermittent fasting. Ann Nutr Metab. 2007;51:88-95.
26. Temizhan A, Tandogan I, Donderici O, etal. The effects of Ramadan fasting on blood lipid levels. Am J Med. 2000;109:341-342.
27. Nematy M, Alinezhad-Namaghi M, Rashed MM, etal. Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study. Nutr J. 2012;11:69. doi: 10.1186/1475-2891-11-69.
28. LeCheminant JD, Christenson E, Bailey BW, etal. Restricting night-time eating reduces daily energy intake in healthy young men: a short-term cross-over study. Br J Nutr. 2013;110:2108-2113.
29. Adlouni A, Ghalim N, Benslimane A, etal. Fasting during Ramadan induces a marked increase in high-density lipoprotein cholesterol and decrease in low-density lipoprotein cholesterol. Ann Nutr Metab. 1997;41:242-249.
30. Fakhrzadeh H, Larijani B, Sanjari M, etal. Effect of Ramadan fasting on clinical and biochemical parameters in healthy adults. Ann Saudi Med. 2003;23:223-226.
31. Zare A, Hajhashemi M, Hassan ZM, etal. Effect of Ramadan fasting on serum heat shock protein 70 and serum lipid profile. Singapore Med J. 2011;52:491-495.
32. Ziaee V, Razaei M, Ahmadinejad Z, etal. The changes of metabolic profile and weight during Ramadan fasting. Singapore Med J. 2006;47:409-414.
33. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford, UK: Oxford Centre for Evidence-Based Medicine. Available at: http://www.cebm.net/index.aspx?o=5653. Accessed Feb. 28, 2014.
34. Preis SR, Pencina MJ, Hwang SJ, etal. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation. 2009;120:212-220.
35. Pencina MJ, D'Agostino RB Sr, Larson MG, etal. Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2009;119:3078-3084.
36. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56:320-328.
37. Wang Y, Yu Q, Chen Y, etal. Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. Curr Pharm Des. 2013;19:4799-4805.
38. Shirani F, Salehi-Abargouei A, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials. Nutrition. 2013;29:939-947.
39. Black MH, Watanabe RM, Trigo E, etal. High-fat diet is associated with obesity-mediated insulin resistance and beta-cell dysfunction in Mexican Americans. J Nutr. 2013;143:479-485.
40. Wang CC, Adochio RL, Leitner JW, etal. Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction. Metabolism. 2013;62:595-603.
41. Shi SQ, Ansari TS, McGuinness OP, etal. Circadian disruption leads to insulin resistance and obesity. Curr Biol. 2013;23:372-381.
42. Hamdy NM. Relationship between pro-anti-inflammatory cytokines, T-cell activation and CA 125 in obese patients with heart failure. Med Sci Monit. 2011;17:CR174-CR179.
43. Bray GA, Clearfield MB, Fintel DJ, etal. Overweight and obesity: the pathogenesis of cardiometabolic risk. Clin Cornerstone. 2009;9:30-40; discussion 41-42.
44. Heggen E, Klemsdal TO, Haugen F, etal. Effect of a low-fat versus a low-glycemic-load diet on inflammatory biomarker and adipokine concentrations. Metab Syndr Relat Disord. 2012;10:437-442.
45. Sawaya AL, Tucker K, Tsay R, etal. Evaluation of four methods for determining energy intake in young and older women: comparison with doubly labeled water measurements of total energy expenditure. Am J Clin Nutr. 1996;63:491-499.
46. Racette SB, Das SK, Bhapkar M, etal. Approaches for quantifying energy intake and %calorie restriction during calorie restriction interventions in humans: the multicenter CALERIE study. Am J Physiol Endocrinol Metab. 2012;302:E441-E448.
47. Vecka M, Dusejovska M, Stankova B, etal. N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia. Neuro Endocrinol Lett. 2012;33(Suppl 2):87-92.
48. Livingstone KM, Lovegrove JA, Givens DI. The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies. Nutr Res Rev. 2012;25:193-206.
49. Ranković G, Djindjić N, Ranković-Nedin G, etal. The effects of physical training on cardiovascular parameters, lipid disorders and endothelial function. Vojnosanit Pregl. 2012;69:956-960.
50. Malagelada JR, Go VL, Summerskill WH. Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals. Dig Dis Sci. 1979;24:101-110.
51. Bogdan A, Bouchareb B, Touitou Y. Ramadan fasting alters endocrine and neuroendocrine circadian patterns. Meal-time as a synchronizer in humans? Life Sci. 2001;68:1607-1615.
52. Leproult R, Van Cauter E. Role of sleep and sleep loss in hormonal release and metabolism. Endocr Dev. 2010;17:11-21.